Director, Hybrid Field Reimbursement & Access Strategy

BridgeBio Pharma Inc.; United States; Hybrid; USD 210,000 - 250,000; Full time

Benefits offered by this job

Market-leading compensation

401(k) with employer match

Employee Stock Purchase Program (ESPP)

Pre-tax commuter benefits

Job summary

BridgeBio Pharma Inc. seeks a Field Reimbursement Leader to shape access strategies and guide a team across the US. You will drive payer engagement, optimize reimbursement pathways, and collaborate with cross-functional teams to ensure compliant, patient-centric access.

The role requires leadership of field teams and deep knowledge of the US payer landscape. This U.S.-based position involves significant travel and a commitment to ethical, high-quality field execution with a focus on rare disease

Qualifications

• Bachelor’s degree required.
• 8–10+ years in biotech/pharma with reimbursement or access focus.
• Experience leading field-based access or reimbursement teams.
• Strong understanding of US payer environments (commercial and government).

Responsibilities

• Lead and oversee field reimbursement strategy aligned with BridgeBio objectives.
• Coach and develop a team of Field Reimbursement Managers.
• Model best-in-class field execution and manage a FRM geography.
• Collaborate with Commercial, Medical, Compliance, Legal, and Market Access.
• Ensure compliance with HIPAA, OIG, and internal policies.

Skills

Leadership experience

Payer strategy

Team development

Biotech/pharma background

US payer environments

Education

Bachelor's degree

MBA or PharmD preferred

Job description

BridgeBio Pharma Inc. seeks a Field Reimbursement Leader to shape access strategies and guide a team across the US. You will drive payer engagement, optimize reimbursement pathways, and collaborate with cross-functional teams to ensure compliant, patient-centric access.

The role requires leadership of field teams and deep knowledge of the US payer landscape. This U.S.-based position involves significant travel and a commitment to ethical, high-quality field execution with a focus on rare disease